SE9601708D0 - Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders - Google Patents

Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders

Info

Publication number
SE9601708D0
SE9601708D0 SE9601708A SE9601708A SE9601708D0 SE 9601708 D0 SE9601708 D0 SE 9601708D0 SE 9601708 A SE9601708 A SE 9601708A SE 9601708 A SE9601708 A SE 9601708A SE 9601708 D0 SE9601708 D0 SE 9601708D0
Authority
SE
Sweden
Prior art keywords
pyrimidyl
pyridyl
treatment
piperazines
substance abuse
Prior art date
Application number
SE9601708A
Other languages
English (en)
Swedish (sv)
Inventor
Anders Bjoerk
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9601708A priority Critical patent/SE9601708D0/xx
Publication of SE9601708D0 publication Critical patent/SE9601708D0/xx
Priority to CA002253473A priority patent/CA2253473A1/en
Priority to PCT/SE1997/000673 priority patent/WO1997041858A1/en
Priority to ES97922236T priority patent/ES2167743T3/es
Priority to EP97922236A priority patent/EP0900082B1/en
Priority to JP9539828A priority patent/JP2000509711A/ja
Priority to AT97922236T priority patent/ATE208197T1/de
Priority to CN97195958A priority patent/CN1111408C/zh
Priority to CZ19983559A priority patent/CZ291107B6/cs
Priority to NZ332484A priority patent/NZ332484A/xx
Priority to PT97922236T priority patent/PT900082E/pt
Priority to IL12679597A priority patent/IL126795A/xx
Priority to BR9708922A priority patent/BR9708922A/pt
Priority to US09/180,292 priority patent/US6221858B1/en
Priority to DK97922236T priority patent/DK0900082T3/da
Priority to RU98122110/14A priority patent/RU2197245C2/ru
Priority to AU27960/97A priority patent/AU704695B2/en
Priority to DE69708084T priority patent/DE69708084T2/de
Priority to HU9902802A priority patent/HUP9902802A3/hu
Priority to NO985063A priority patent/NO316611B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9601708A 1996-05-06 1996-05-06 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders SE9601708D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9601708A SE9601708D0 (sv) 1996-05-06 1996-05-06 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
HU9902802A HUP9902802A3 (en) 1996-05-06 1997-04-22 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
CZ19983559A CZ291107B6 (cs) 1996-05-06 1997-04-22 Lék pro zmírnění nebo prevenci abstinenčního syndromu
PT97922236T PT900082E (pt) 1996-05-06 1997-04-22 Utilizacao de piridilpiperazina e pirimidilpiperazina para o fabrico de um medicamento para o tratamento de perturbacoes de toxicomania
ES97922236T ES2167743T3 (es) 1996-05-06 1997-04-22 Uso de piridil- y pirimidil-piperazinas en la preparacion de un medicamento para el tratamiento de trastornos derivados del abuso de substancias.
EP97922236A EP0900082B1 (en) 1996-05-06 1997-04-22 Use of pyridyl- and pyrimidyl-piperazines for the manufacture of a medicament for the treatment of substance abuse disorders
JP9539828A JP2000509711A (ja) 1996-05-06 1997-04-22 物質濫用障害の処置におけるピリジル―およびピリミジル―ピペラジン
AT97922236T ATE208197T1 (de) 1996-05-06 1997-04-22 Verwendung von pyridyl- und pyrimidyl-piperazinen zur herstellung eines medikaments zur behandlung von rauschgiftsbedingten beschwerden
CN97195958A CN1111408C (zh) 1996-05-06 1997-04-22 药物滥用疾病治疗中的吡啶基－和嘧啶基－哌嗪类化合物
CA002253473A CA2253473A1 (en) 1996-05-06 1997-04-22 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
NZ332484A NZ332484A (en) 1996-05-06 1997-04-22 use of pyridyl and pyrimidyl substituted piperazine derivatives for treating substance abuse disorders
PCT/SE1997/000673 WO1997041858A1 (en) 1996-05-06 1997-04-22 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
IL12679597A IL126795A (en) 1996-05-06 1997-04-22 Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
BR9708922A BR9708922A (pt) 1996-05-06 1997-04-22 Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
US09/180,292 US6221858B1 (en) 1996-05-06 1997-04-22 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders
DK97922236T DK0900082T3 (da) 1996-05-06 1997-04-22 Anvendelse af pyridyl- og pyrimidyl-piperaziner til fremstilling af et lægemiddel til behandling af rusgiftbetingede lidelser
RU98122110/14A RU2197245C2 (ru) 1996-05-06 1997-04-22 Пиридил- и пиримидил-пиперазины в лечении болезней, вызываемых злоупотреблением лекарственными и/или наркотическими веществами
AU27960/97A AU704695B2 (en) 1996-05-06 1997-04-22 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders
DE69708084T DE69708084T2 (de) 1996-05-06 1997-04-22 Verwendung von pyridyl- und pyrimidyl-piperazinen zur herstellung eines medikaments zur behandlung von rauschgiftsbedingten beschwerden
NO985063A NO316611B1 (no) 1996-05-06 1998-10-30 Anvendelse av pyridyl- og pyrimidylpiperaziner i behandling av substansmisbruksforstyrrelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601708A SE9601708D0 (sv) 1996-05-06 1996-05-06 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders

Publications (1)

Publication Number Publication Date
SE9601708D0 true SE9601708D0 (sv) 1996-05-06

Family

ID=20402456

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601708A SE9601708D0 (sv) 1996-05-06 1996-05-06 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders

Country Status (20)

Country Link
US (1) US6221858B1 (no)
EP (1) EP0900082B1 (no)
JP (1) JP2000509711A (no)
CN (1) CN1111408C (no)
AT (1) ATE208197T1 (no)
AU (1) AU704695B2 (no)
BR (1) BR9708922A (no)
CA (1) CA2253473A1 (no)
CZ (1) CZ291107B6 (no)
DE (1) DE69708084T2 (no)
DK (1) DK0900082T3 (no)
ES (1) ES2167743T3 (no)
HU (1) HUP9902802A3 (no)
IL (1) IL126795A (no)
NO (1) NO316611B1 (no)
NZ (1) NZ332484A (no)
PT (1) PT900082E (no)
RU (1) RU2197245C2 (no)
SE (1) SE9601708D0 (no)
WO (1) WO1997041858A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL203140B1 (pl) 1997-10-27 2009-08-31 Neurosearch As Pochodna homopiperazyny, kompozycja farmaceutyczna zawierająca te pochodne i zastosowanie tej pochodnej
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
FR2827172B1 (fr) * 2001-07-13 2004-07-02 Pf Medicament Derives de pyridin-2-yl-methylamine pour le traitement de la dependance aux opioides
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299928A (en) 1980-03-14 1981-11-10 Mobay Chemical Corporation Impact modified polycarbonates
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders

Also Published As

Publication number Publication date
CA2253473A1 (en) 1997-11-13
CN1111408C (zh) 2003-06-18
CN1223583A (zh) 1999-07-21
HUP9902802A3 (en) 2002-01-28
NO316611B1 (no) 2004-03-08
HUP9902802A2 (hu) 2000-05-28
IL126795A (en) 2003-05-29
NO985063D0 (no) 1998-10-30
ES2167743T3 (es) 2002-05-16
CZ291107B6 (cs) 2002-12-11
BR9708922A (pt) 1999-08-03
IL126795A0 (en) 1999-08-17
NO985063L (no) 1999-01-05
AU704695B2 (en) 1999-04-29
RU2197245C2 (ru) 2003-01-27
NZ332484A (en) 2001-01-26
WO1997041858A1 (en) 1997-11-13
DE69708084T2 (de) 2002-06-06
PT900082E (pt) 2002-04-29
DK0900082T3 (da) 2002-02-18
DE69708084D1 (de) 2001-12-13
JP2000509711A (ja) 2000-08-02
ATE208197T1 (de) 2001-11-15
CZ355998A3 (cs) 1999-06-16
EP0900082B1 (en) 2001-11-07
EP0900082A1 (en) 1999-03-10
US6221858B1 (en) 2001-04-24
AU2796097A (en) 1997-11-26

Similar Documents

Publication Publication Date Title
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
NO175259C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triazolo-1,4-diazepinforbindelser
MY107157A (en) Quinuclidine derivatives.
MX9707453A (es) Derivados de quinazolina.
TNSN06036A1 (en) Pyridyl derivatives and their use as therapeutic agents
NZ514487A (en) Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
WO1999012532A3 (en) Piperidine derivatives against malaria
NZ514037A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
YU50302A (sh) Nova heterociklična jedinjenja, njihove soli i njihova primena u medicini
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NZ524742A (en) Bridged piperazine derivatives
SE9601708D0 (sv) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
NO950731L (no) Optisk aktive karboksamidderivater
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
SE9603284D0 (sv) New compounds
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
DE69132036D1 (de) Wirkstoff zur Behandlung der Drogenabhängigkeit
MX9803271A (es) Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica.
EA199700053A1 (ru) Новые применения 2-[n-(1,2-бензизотиазолил-3(2h)он-1,1-диоксид]этил 5-этоксикарбонил-2,4,6-триметил-1,4-дигидропиридин-3-карбоксилата